Antibody recognition of chiral surfaces. Enantiomorphous crystals of leucine-leucine-tyrosine

Journal of the American Chemical Society

Volumn 125, Issue 3, 2003, Pages 696-704

  Geva, Merav ^a   Frolow, Felix ^a,b   Eisenstein, Miriam ^a   Addadi, Lia ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; IMMUNIZATION; MOLECULAR CRYSTALS;

ENANTIOMERS;

ENZYMES;

LEUCINE; META TYROSINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 48E; MONOCLONAL ANTIBODY 602E; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CHIRALITY; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLIZATION; ENANTIOMER; ENANTIOSELECTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PROTEIN PROTEIN INTERACTION; STEREOCHEMISTRY; STRUCTURE ANALYSIS; SYNTHESIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; CRYSTALLIZATION; CRYSTALLOGRAPHY, X-RAY; FEMALE; IMMUNIZATION; MICE; MICE, INBRED BALB C; MODELS, MOLECULAR; OLIGOPEPTIDES; PROTEIN CONFORMATION; STEREOISOMERISM; SURFACE PROPERTIES;

EID: 0037460136     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja027942j     Document Type: Article

References (40)

1. We chose to use here the notation commonly used for amino acids, namely, L and D. We note that the correct notation, following Cahn Ingold and Prelog rules, is -leucine-(S)-leucine-(S)-tyrosine for the L-enantiomer and(R)-leucine-(R)-leucine-(R)-tyrosine for the D-enantiomer
2. Aizenherg, J.; Hanson, J.; Koetzle, T.; Leiserowitz, L.; Weiner, S.; Addadi, L. Chem. - Eur. J. 1995, 1, 414-422.
3. Young, J. R.; Davis, S. A.; Bown, P. R.; Mann, S. J. Struct. Biol. 1999, 126, 195-215.
4. Mann, S.; Sparks, N. H. C.; Blakemore, R. P. Proc. R. Soc. London, B 1987, 231, 477-487.
5. Bouropoulos, N.; Weiner, S.; Addadi, L. Chem, - Eur. J. 2001, 7, 1881-1888.
6. Laursen, R. A.; Wen, D. Y.; Knight, C. A. J. Am. Chem. Soc. 1994, 116, 12057-12058.
7. Wierzbicki, A.; Taylor, M. S.; Knight, C. A.; Madura, J. D.; Harrington, J. P.; Sikes, C. S. Biophys. J. 1996, 71, 8-18.
8. Orme, C. A.; Noy, A.; Wierzbicki, A.; McBride, M. T.; Grantham, M. T., H. H.; Dove, P. M.; DeYoreo, J. J. Nature 2001, 411, 775-779.
9. Lahiri, L.; Xu, G.; Dabbs, D. M.; Yao, N.; Aksay, I. A.; Groves, J. T. J. Am. Chem. Soc. 1997, 119, 5449-5450.
10. Landau, E. M.; Levanon, M.; Leiserowitz, L.; Lahav, M.; Sagiv, J. Nature 1985, 318, 353-356.
11. Weissbuch, I.; Addadi, L.; Lahav, M.; Leizerowitz, L. Science 1991, 253, 637-645.
12. Addadi, L.; Berkovitch-Yellin, Z.; Weissbuch, I.; Lahav, M.; Leiserowitz, L.; Weinstein, S. J. Am. Chem. Soc, 1982, 104, 2075.
13. Lahav, M.; Leiserowitz, L. Angew. Chem., Intl. Ed. 1999, 38, 2533-2536.
14. Bromberg, R.; Kessler, N.; Addadi, L. J Cryst. Growth 1998, 193, 656-664.
15. Kessler, N.; Perl-Treves, D.; Addadi, L.; Eisenstein, M. Proteins: Struct., Funct. Genet. 1999, 34, 383-394.
16. Guichard, G.; Benkirane, N.; Zeder-Lutz, G.; Van-Regenmortel, M. H. V.; Briand, J. P.; Muller, S. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 9765-9769.
17. Hofstetter, O.; Hofstetter, H.; Schurig, V.; Wilchek, M.; Green, B. S. J. Am. Chem. Soc. 1998, 120, 3251-3252.
18. Lee, S. B.; Mitchell, D. T.; Trofin, L.; Nevanen, T. K.; Soderlund, H.; Martin, C. R. Science 2002, 292, 2198-2200,
19. Mislow, K.; Bickart, P. Isr. J. Chem. 1977, 15, 1-6.
20. Zabrodsky, H.; Avnir, D. J. Am. Chem. Soc. 1995, 117, 462-473.
21. Perl-Treves, D.; Kessler, N.; Izhaky, D.; Addadi, L. Chem. Biol. 1996, 3, 567-577.
22. Izhaky, D.; Addadi, L. Adv. Mater. 1998, 10, 1009-1013.
23. Geva, M.; Izhaky, D.; Mickus, D. E.; Rychnovsky, S. D.; Addadi, L. ChemBioChem 2001, 2, 265-271.
24. Berthou, J.; Migliore-Samour, D.; Lifchitz, A.; Delletre, J.; Floch, F.; Jolles, P. FEBS Lett. 1987, 218, 55-58.
25. Abbas, A. K. Cellular and Molecular Immunology, 2nd ed.; W. B. Saunders Co.: Philadelphia, 1994.
26. Fridkin, M.; Hazum, E.; Tauber-Finkelstein, M.; Shaltiel, S. Arch. Biochem. Biophys. 1977, 178, 517-526.
27. Addadi, L.; Berkovitch-Yellin, Z.; Weissbuch, I.; Lahav, M.; Leiserowitz, L. In Topics in Stereochemistry; Eliel, E. L., Wilen, S. H., Allinger, N. H., Eds.; John Wiley & Sons: New York, 1986, Vol. 16.
28. Kessler, N.; Perl-Treves, D.; Addadi, L. FASEB J. 1996, 10, 1435-1442.
29. Kohler, G.; Milstein, C. Nature 1974, 256, 495-497.
30. Eshhar, Z. In Monoclonal antibody strategy and techniques; Springer, T. A., Ed.; Plenum Press: New York, 1985; pp 3-41.
31. Katchalski-Katzir, E.; Shariv, I.; Eisenstein, M.; Friesem, A. A.; Aflalo, C.; Vakser, I. A. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 2195-2199.
32. Eisenstein, M.; Shariv, I.; Koren, G.; Friesem, A. A.; Katchalski-Katzir, E. J. Mol. Biol. 1997, 266, 135-143.
33. Eisenstein, M.; Katchalski-Katzir, E. Lett. Pept. Sci. 1998, 5, 365-369.
34. Liou, Y. C.; Tocilj, A.; Davies, P. L.; Jia, Z. C. Nature 2000, 406, 322-324.
35. Graether, S. P.; Kuiper, M. J.; Gagne, S. M.; Walker, V. K.; Jia, Z. C.; Sykes, B. D.; Davies, P. L. Nature 2000, 406, 325-328.
36. Simons, K.; Ikonen, E. Nature 1997, 387, 569-572.
37. Simons, K.; Toomre, D. Nat. Rev. Mol. Cell Biol. 2000, 1, 31-39.
38. Chochina, S. V.; Avdulov, N. A.; Igbavboa, U.; Cleary, J. P.; O'Hare, E. O.; Wood, W. G. J. Lipid Res. 2001, 42, 1292-1297.
39. Ono, A.; Freed, E. O. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 13925-13930.
40. Kruth, H. S.; Ifrim, I.; Chang, J.; Addadi, L.; Perl-Treves, D.; Zhang, W. Y. J. Lipid Res. 2001, 42, 1492-1500.